Manuel A. Pascual

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


340 publications

In press | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ...
 
Nonvascularized human skin chronic allograft rejection.
Rotman S., Koch N., Wiesner L., Aubert V., Rosales I.A., Colvin R.B., Raffoul W., Pascual M. American journal of transplantation. Peer-reviewed.
 
Burden of end-stage renal disease and evolving challenges in kidney transplantation.
Golshayan D., Pascual M., 2019/09. Transplant international, 32 (9) pp. 889-891. Peer-reviewed.
 
Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Kaminski H., Jarque M., Halfon M., Taton B., Di Ascia L., Pfirmann P., Visentin J., Garrigue I., Déchanet-Merville J., Moreau J.F. et al., 2019/07/31. The Journal of infectious diseases, 220 (5) pp. 761-771. Peer-reviewed.
 
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
Fraga M., Gouttenoire J., Sahli R., Chtioui H., Marcu C., Pascual M., Moradpour D., Vionnet J., 2019/05/24. BMC gastroenterology, 19 (1) p. 76. Peer-reviewed.
 
Evaluation of donor kidneys prior to transplantation: an update of current and emerging methods.
Moeckli B., Sun P., Lazeyras F., Morel P., Moll S., Pascual M., Bühler L.H., 2019/05. Transplant international, 32 (5) pp. 459-469. Peer-reviewed.
 
Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: A systematic review and meta-analysis.
Fernández-Ruiz M., Giménez E., Lora D., Aguado J.M., Pascual M., Manuel O., 2019/04. American journal of transplantation, 19 (4) pp. 1072-1085. Peer-reviewed.
 
Variations et anomalies néphrologiques, vasculaires et urologiques chez les candidats au don vivant rénal [Renal, vascular and urological variations and abnormalities in living kidney donor candidates]
Costa A., Matter M., Pascual M., Doerfler A., Venetz J.P., 2019/03. Progres en urologie, 29 (3) pp. 166-172. Peer-reviewed.
 
Genetic and clinic predictors of new onset diabetes mellitus after transplantation.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Mueller N.J., Binet I., Van Delden C., Steiger J., Mohacsi P. et al., 2019/02. The pharmacogenomics journal, 19 (1) pp. 53-64. Peer-reviewed.
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. Data in brief, 21 pp. 2567-2575. Peer-reviewed.
 
The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. International immunopharmacology, 65 pp. 483-492. Peer-reviewed.
 
Efficient B cell Depletion With Rituximab Despite Massive Proteinuria.
Halfon M., Pascual M., Aubert V., Rotman S., Yannick M.D., 2018/10. Transplantation, 102 (10) pp. e401-e402. Peer-reviewed.
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
 
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N., Koutsokera A., Pasquier J., Mombelli M., Meylan P., Pascual M., Aubert J.D., Manuel O., 2018/08. Transplant infectious disease, 20 (4) pp. e12893. Peer-reviewed.
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.
Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M., 2018/06. Transplantation, 102 (6) pp. e301-e303. Peer-reviewed.
 
Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation.
Vionnet J., Yerly P., Aubert J.D., Pascual M., Aldenkortt F., Berney T., Giostra E., Moradpour D., Schiffer E., 2018/05. Transplantation, 102 (5) pp. e194. Peer-reviewed.
 
Xenotransplantation: back to the future?
Meier RPH, Muller Y.D., Balaphas A., Morel P., Pascual M., Seebach J.D., Buhler L.H., 2018/05. Transplant international, 31 (5) pp. 465-477. Peer-reviewed.
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller Y.D., Ghaleb N., Rotman S., Vionnet J., Halfon M., Catana E., Golshayan D., Venetz J.P., Aubert V., Pascual M., 2018/04. Transplant international, 31 (4) pp. 451-455. Peer-reviewed.
Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature.
Libudzic-Nowak A.M., Cachat F., Pascual M., Chehade H., 2018. Frontiers in pediatrics, 6 p. 398. Peer-reviewed.
 
Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study.
Gero D., Dib F., Matter M., Pascual M., Venetz J.P., Demartines N., Melloul E., 2017/11. World journal of surgery, 41 (11) pp. 2940-2948. Peer-reviewed.
 
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation [PLB069]
Muller Y, Ghaleb N., Rotman S, Catana E., Golshayan D, Venetz JP, Aubert V., Pascual M., 2017/10/31. pp. 553-554 dans Transplant International.
 
Early acute antibody-mediated rejection (AMR) after lung transplantation successfully treated with c5 blockade [PLB032]
Muller Y., Aubert JD, Vionnet J., Rotman S., Aubert V, Pascual M., 2017/09/30. pp. 543-543 dans Transplant International.
 
Late hepatitis B reactivation following direct-acting antiviral-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
Vionnet J., Pascual M., Testoni B., Combet C., Godat S., Vijgen S., Aubert V., Rubbia-Brandt L., Zoulim F., Moradpour D., 2017/09/16. Hepatology, 67 (2) pp. 791-793 . Peer-reviewed.
 
The impact of multidisciplinary care on early morbidity and mortality after heart transplantation.
Schmidhauser M., Regamey J., Pilon N., Pascual M., Rotman S., Banfi C., Prêtre R., Meyer P., Antonietti J.P., Hullin R., 2017/09/01. Interactive cardiovascular and thoracic surgery, 25 (3) pp. 384-390. Peer-reviewed.
 
Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C., Stampf S., Héquet D., Mueller N.J., Cusini A., van Delden C., Khanna N., Boggian K., Hirzel C., Soccal P. et al., 2017/07. American journal of transplantation, 17 (7) pp. 1813-1822. Peer-reviewed.
 
A Renal Paratransplant Hernia Causing Complete Small Bowel Obstruction: A Case Report and Review of the Literature.
Zingg T., Teixeira Farinha H., Demartines N., Pascual M., Matter M., 2017. Transplantation proceedings, 49 (1) pp. 210-212. Peer-reviewed.
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice.
Govender L., Wyss J.C., Kumar R., Pascual M., Golshayan D., 2017. Frontiers in immunology, 8 p. 421. Peer-reviewed.
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
Obregon C., Kumar R., Pascual M.A., Vassalli G., Golshayan D., 2017. Frontiers in immunology, 8 p. 1514. Peer-reviewed.
 
Blockade of C5 in Severe Acute Postinfectious Glomerulonephritis Associated With Anti-Factor H Autoantibody.
Chehade H., Rotman S., Frémeaux-Bacchi V., Aubert V., Sadallah S., Sifaki L., Salomon R., Pascual M., 2016/12. American journal of kidney diseases : the official journal of the National Kidney Foundation, 68 (6) pp. 944-948. Peer-reviewed.
 
Oral valganciclovir for CMV gastritis.
Saouli A.C., Salvade I., Saldarriaga J., Manuel O., Venetz J.P., Golshayan D., Sempoux C., Pascual M., 2016/09. Clinics and research in hepatology and gastroenterology, 40 (4) pp. e50-1. Peer-reviewed.
 
Amyloïdose héréditaire à transthyrétine [Transthyretin-related hereditary amyloidosis]
Vionnet J., Pascual M., Kuntzer T., Yerly P., Moradpour D., 2016/08/31. Revue medicale suisse, 12 (528) pp. 1434-1440. Peer-reviewed.
 
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D., Pascual M., Lartey S., Pathirana R.D., Bredholt G., Hoschler K., Hullin R., Meylan P., Cox R.J., Manuel O., 2016/06/30. Vaccine, 34 (31) pp. 3576-3583. Peer-reviewed.
 
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I., Aubert V., Venetz J.P., Golshayan D., Saouli A.C., Matter M., Rotman S., Pantaleo G., Pascual M., 2016/06. Human immunology, 77 (6) pp. 483-489. Peer-reviewed.
 
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D., Wójtowicz A., Bibert S., Pyndiah N., Manuel O., Binet I., Buhler L.H., Huynh-Do U., Mueller T., Steiger J. et al., 2016/04. Kidney international, 89 (4) pp. 927-938. Peer-reviewed.
 
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
Vijgen S., Wyss C., Meylan P., Bisig B., Letovanec I., Manuel O., Pascual M., de Leval L., 2016. Transplantation, 100 (1) pp. 134-140. Peer-reviewed.
Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
Michaud L., Ludwig G., Berney S., Rodrigues S., Niquille A., Santschi V., Favre A.S., Lange A.C., Michels A.A., Vrijens B. et al., 2016. Pharmacy practice, 14 (4) p. 822. Peer-reviewed.
Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.
Lorent M., Giral M., Pascual M., Koller M.T., Steiger J., Trébern-Launay K., Legendre C., Kreis H., Mourad G., Garrigue V. et al., 2016. Plos One, 11 (5) pp. e0155278. Peer-reviewed.
 
The Challenge of Acute Antibody-Mediated Rejection in Kidney Transplantation.
Chehade H., Pascual M., 2016. Transplantation, 100 (2) pp. 264-265. Peer-reviewed.
 
Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease.
Vionnet J., Saouli A.C., Pascual M., Stucker F., Decosterd L.A., Moradpour D., Chtioui H., 2016. Journal of Hepatology, 65 (5) pp. 1063-1065. Peer-reviewed.
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Héquet D., Kralidis G., Carrel T., Cusini A., Garzoni C., Hullin R., Meylan P.R., Mohacsi P., Mueller N.J., Ruschitzka F. et al., 2016. Bmc Infectious Diseases, 16 p. 321. Peer-reviewed.
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Wojtowicz A., Bibert S., Beckmann S., Mueller N.J., Binet I. et al., 2016. PloS one, 11 (10) pp. e0164443. Peer-reviewed.
 
Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.
Roehrich M.E., Wyss J.C., Kumar R., Pascual M., Golshayan D., Vassalli G., 2015. Immunopharmacology and Immunotoxicology, 37 (5) pp. 434-441. Peer-reviewed.
 
Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy.
Halfon M., Rotman S., Egli M., Venetz J.P., Pascual M., 2015. Acta Diabetologica, 52 (6) pp. 1175-1177. Peer-reviewed.
 
Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient.
Chehade H., Rotman S., Matter M., Girardin E., Aubert V., Pascual M., 2015. Pediatrics, 135 (2) pp. e551-e555. Peer-reviewed.
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
Wójtowicz A., Gresnigt M.S., Lecompte T., Bibert S., Manuel O., Joosten L.A., Rüeger S., Berger C., Boggian K., Cusini A. et al., 2015. Journal of Infectious Diseases, 211 (10) pp. 1646-1657. Peer-reviewed.
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
Manuel O., Wójtowicz A., Bibert S., Mueller N.J., van Delden C., Hirsch H.H., Steiger J., Stern M., Egli A., Garzoni C. et al., 2015. Journal of Infectious Diseases, 211 (6) pp. 906-914.
 
Le rôle des associations de patients face au don d'organes en Suisse romande [Organ donation and the role of patients' associations in Western Switzerland].
Kaech F., Barras V., Pascual M., Hammer R., 2015. Revue Médicale Suisse, 11 (496) pp. 2250-2253.
 
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Hirsch H. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (4) pp. 619-622. Peer-reviewed.
Reply to Cunha et al.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Khanna N. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (12) pp. 1894-1895. Peer-reviewed.
Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
Vionnet J., Pascual M., Chtioui H., Giostra E., Majno P.E., Decosterd L.A., Moradpour D., 2015. BMC Gastroenterology, 15 (1) p. 38. Peer-reviewed.
 
The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation.
Martin-Gandul C., Mueller N.J., Pascual M., Manuel O., 2015. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15 (12) pp. 3024-3040.
 
Time-Dependent Specificity of Immunopathologic (C4d-CD68) and Histologic Criteria of Antibody-Mediated Rejection for Donor-Specific Antibodies and Allograft Dysfunction in Heart Transplantation.
Yerly P., Rotman S., Nobile A., Aubert V., Tozzi P., Yarol N., Vogt P., Hullin R., Pascual M., 2015. Transplantation, 99 (3) pp. 586-593.
 
Transition en transplantation rénale [Transition in kidney transplantation].
Chehade H., Parvex P., Venetz J.P., Hadaya K., Typaldou S.A., Villard E., Vogeleisen C., Pilon N., Cachat F., Pascual M., 2015. Revue Médicale Suisse, 11 (462) pp. 456, 458-456, 460. Peer-reviewed.
 
Does the intermed instrument predict medication adherence in transplant recipients?
Schneider Marie P., Ludwig Gundula, Rodrigues Stephanie, Niquille Anne, Santschi Valerie, Lange Anne-Catherine, Favre Anne-Sophie, Bugnon Olivier, Pascual Manuel, Michaud Laurent et al., 2014. dans 18th Annual ESPACOMP Meeting.
 
Facteurs influençant le retour au travail après transplantation chez 61 patients rénaux ou hépatiques
Praz-Christinaz Sophie-Maria, Pascual Manuel, Pilon Nathalie, Simcox Amira, Wild Pascal, Danuser Brigitta, 2014. Revue Médicale Suisse, 10 (431) pp. 1148-1152. Peer-reviewed.
 
Heart donation after circulatory determination of death: ethically acceptable?
Dalle Ave A.L., Shaw D.M., Pascual M., Benaroyo L., 2014. Nature Reviews. Cardiology, 11 (9) p. 553. Peer-reviewed.
 
Hepatitis C Virus Infection and Kidney Transplantation in 2014: What's New?
Baid-Agrawal S., Pascual M., Moradpour D., Somasundaram R., Muche M., 2014. American Journal of Transplantation, 14 (10) pp. 2206-2220.
 
Histological and immunological aspects of chronic skin allograft rejection
Rotman S., Aubert V., Koch N., Raffoul W., Pascual M., 2014. dans 80th annual congress of the Swiss Society of Pathology.
 
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F., Pascual M., Hullin R., Yerly P., Tozzi P., Meylan P., Manuel O., 2014. Transplantation, 97 (11) pp. 1192-1197.
 
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., 2014. Transplant International, 27 (9) pp. 903-908.
 
Potential and limitations of regulatory T-cell therapy in solid organ transplantation.
Govender L., Pascual M., Golshayan D., 2014. Expert Review of Clinical Immunology, 10 (9) pp. 1197-1212.
 
Approche interdisciplinaire de la decision de don d'organes: l'experience lausannoise [An interdisciplinary approach of the organ donation decision: the Lausanne's experience].
Bosisio F., Merminod G., Burger M., Pascual M., Moretti D., Benaroyo L., 2013. Revue Médicale Suisse, 9 (408) pp. 2249-2253.
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.
Koller M.T., van Delden C., Müller N.J., Baumann P., Lovis C., Marti H.P., Fehr T., Binet I., De Geest S., Bucher H.C. et al., 2013. European Journal of Epidemiology, 28 (4) pp. 347-355.
 
European survey on the management of tuberculosis in solid-organ transplant recipients and candidates.
Boillat-Blanco N., Aguado J.M., Aubert J.D., Sester M., Grossi P., Kamar N., Pascual M., Manuel O., ESCMID Study Group of Infection in Compromised Hosts (ESGICH), 2013. Transplant International, 26 (8) pp. e69-e70. Peer-reviewed.
 
Evolving Trends in the Costs Associated With Hospital Use of Immunosuppressive Drugs.
Perrottet N., Aubert V., Venetz J.P., Ugolini E., Matter M., Pannatier A., Pascual M., 2013. Transplantation, 95 (5) pp. e24-e25.
 
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
Manuel O., Kralidis G., Mueller N.J., Hirsch H.H., Garzoni C., van Delden C., Berger C., Boggian K., Cusini A., Koller M.T. et al., 2013. American Journal of Transplantation, 13 (9) pp. 2402-2410.
 
Liver Transplantation for Neuroendocrine Tumors in Europe-Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study.
Le Treut Y.P., Grégoire E., Klempnauer J., Belghiti J., Jouve E., Lerut J., Castaing D., Soubrane O., Boillot O., Mantion G. et al., 2013. Annals of Surgery, 257 (5) pp. 807-815.
 
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
Schmidtko J., Peine S., El-Housseini Y., Pascual M., Meier P., 2013. American Journal of Kidney Diseases, 61 (2) pp. 289-299. Peer-reviewed.
 
Relevance of cohort studies for the study of transplant infectious diseases.
Berger C., Boggian K., Cusini A., van Delden C., Garzoni C., Hirsch H.H., Khanna N., Koller M., Manuel O., Meylan P. et al., 2012/12. Current opinion in organ transplantation, 17 (6) pp. 581-585. Peer-reviewed.
 
MR imaging as a specific diagnostic tool for bilateral microcysts in chronic lithium nephropathy.
Golshayan D., Nseir G., Venetz J.P., Pascual M., Barbey F., 2012/03. Kidney International, 81 (6) p. 601. Peer-reviewed.
Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease.
Friedrich L., Barbey F., Pascual M., Venetz J.P., 2012. Case Reports in Transplantation, 2012 p. 513025.
 
Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient.
Chehade H., Girardin E., Delich V., Pascual M.A., Venetz J.P., Cachat F., 2012. Transplant Infectious Disease, 14 (4) pp. E27-E29.
 
Effects of immunosuppressive drugs on T helper cells subsets and potential to promote tolerance in a stringent experimental transplantation model.
Wyss J.C., Govender L., Pascual M., Golshayan D., 2012. pp. 462-463 dans American Transplant Congress 2012, American Journal of Transplantation. Peer-reviewed.
 
Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.
Manuel O., Baid-Agrawal S., Moradpour D., Pascual M., 2012. Contributions to Nephrology, 176 pp. 97-107.
 
Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients.
Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P., Manuel O., 2012. Transplantation, 94 (6) pp. 630-636. Peer-reviewed.
 
Rejets aigus
Venetz J.P., Pascual M., 2012. pp. 449-464 dans Legendre C. (eds.) Transplantation Rénale chap. 38, Médecine Sciences Publications.
 
Strength and limitations of regulatory T Cells for immunotherapy in transplantation.
Govender L., Wyss J.C., Pascual M., Golshayan D., 2012. p. 448 dans American Transplant Congress 2012, American Journal of Transplantation. Peer-reviewed.
 
The definition of quality of life in solid organ transplantation: A psychological qualitative model
Piot-Ziegler C., Aubert J.D., Pascual M., 2011/09., the 15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics p. 246 dans Transplant international. Peer-reviewed.
 
A model for organ donation in switzerland, the latin organ donation programme (lodp); an ongoing successful regional initiative
Moretti D., Heidegger C.P., Eckert P., Malacrida R., Pascual M., Revelly J.P., 2011. p. 153 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
Diagnostic de la mort dans le contexte de la transplantation d'organes. Les directives.
Commission Centrale d'Ethique de l'ASSM, 2011. Bulletin des Médecins Suisses, 92 (32-33) pp. 1208-1210.
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., 2011. Clinical Infectious Diseases, 52 (2) pp. 248-256.
 
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N., Pascual M., Venetz J.P., Nseir G., Meylan P.R., Manuel O., 2011. Transplantation, 91 (2) pp. 251-255.
 
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
Lange C.M., Moradpour D., Doehring A., Lehr H.A., Müllhaupt B., Bibert S., Bochud P.Y., Antonino A.T., Pascual M., Farnik H. et al., 2011. Journal of Hepatology, 55 (2) pp. 322-327.
 
Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
Jankovic J., Pascual M., Venetz J.P., Nseir G., Meylan P., Manuel O., 2011. p. 323 dans ATC 2011, American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
Manuel O., Humar A., Berutto C., Ely L., Giulieri S., Lien D., Meylan P.R., Weinkauf J., Pascual M., Nador R. et al., 2011. Journal of Heart and Lung Transplantation, 30 (6) pp. 679-684.
 
Monitoring of CD4(+)CD25(high)IL-7R alpha(high) activated T Cells in Kidney Transplant Recipients
Vallotton L., Hadaya K., Venetz J.P., Buehler L.H., Ciuffreda D., Nseir G., Codarri L., Villard J., Pantaleo G., Pascual M., 2011. Clinical Journal of the American Society of Nephrology, 6 (8) pp. 2025-2033.
 
Overlapping Pathways to Transplant Glomerulopathy: Chronic Humoral Rejection, Hepatitis C Infection and Thrombotic Microangiopathy
Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., Collins A.B., Colvin R.B., 2011. p. 401 dans ATC 2011, American Transplant Congress, American Journal of Transplantation.
 
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy.
Baid-Agrawal S., Farris A.B., Pascual M., Mauiyyedi S., Farrell M.L., Tolkoff-Rubin N., Collins A.B., Frei U., Colvin R.B., 2011. Kidney International, 80 (8) pp. 879-885.
 
Partager la vie : témoignages
Pascual M., 2011. pp. 160-173 dans Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.) Le sang : Arts, Sciences, Vie, Favre.
 
Prise en charge psychologique en transplantation d'organes : quel accompagnement pour les patients?
Piot-Ziegler C., Pascual M., 2011. Encyclopédie Médico-Chirurgicale, EMC pp. 1-44. Peer-reviewed.
 
Programme latin de don d'organes (PLDO): une initiative efficace pour augmenter les dons d'organes en Suisse [Latin organ donation programme (LODP): an effective initiative to increase organ donation in Switzerland].
Heidegger C.P., Moretti D., Eckert P., Malacrida R., Pascual M., Revelly J.P., 2011. Revue Médicale Suisse, 7 (300) pp. 1368-1371.
 
Renal transplantation following aorto-iliac reconstruction is a safe a strategy
Dubuis C., Deglise S., Saucy F., Saint-Lebes B., Venetz J.P., Pascual M., Corpataux J.M., 2011. p. 284 dans 15th Congress of the European Society for Organ Transplantation and 22nd Annual Conference of the British Society for Histocompatibility and Immunogenetics, Transplant international. Peer-reviewed.
 
Sélection et suivi prétransplantation des patients candidats à la greffe cardiaque en Suisse romande [Selection and preoperative follow-up of heart transplantation candidates in the French part of Switzerland].
Yarol N., Tozzi P., von Segesser L., Kalangos A., Vogt P., Yerly P., Mach F., Pascual M., Meyer P., Hullin R., 2011. Revue Médicale Suisse, 7 (297) pp. 1212-1216.
 
Transplantation tolerance: Clinical potential of regulatory T cells.
Muller Y.D., Seebach J.D., Bühler L.H., Pascual M., Golshayan D., 2011. Self/nonself, 2 (1) pp. 26-34.
 
Treatment of Recurrent Hepatitis C after Liver Transplantation with PEG-Interferon and Ribavirin.
Antonino A.T., Fontana M., Gioastra E., Moradpour D., Pascual M., 2011. pp. S149 dans Joint International Congress of ILTS (International Liver Transplantation Society), ELITA (European Society for Organ Transplantation) and LICAGE (Liver Intensive Care Group of Europe), Liver Transplantation. Peer-reviewed.
 
Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland.
Jackson Y., Dang T., Schnetzler B., Pascual M., Meylan P., 2011. Journal of Heart and Lung Transplantation, 30 (4) pp. 484-485.
 
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Manuel O., Perrottet N., Pascual M., 2011. Expert Review of Anti-infective Therapy, 9 (11) pp. 955-965.
 
Recommandations suisses pour la prise en charge des cancers cutanés chez les patients transplantés d'organe [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]
Lapointe A.K., Hofbauer G., Anliker M., Arnold A., Binet I., Hunger R., Kempf W., Pascual M., Pelloni F., Serra A. et al., 2010/04/28. Revue medicale suisse, 6 (246) pp. 854-859.
 
A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Influenza Vaccine in Lung Transplant Recipients
Manuel O, Humar A., Berutto C., Lien D., Giulieri S., Weinkauf J., Meylan P.R., Ely L., Pascual M., Nador R. et al., 2010. p. 208 dans 10th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Absence of residual Hodgkin's disease demonstrated by PET/CT in a deceased organ donor.
Prior J.O., Duchosal M.A., Schmidt S., Turini P., Pilon N., Chioléro R., Pascual M., 2010/01. Transplant international, 23 (1) pp. 101-104. Peer-reviewed.
 
Differential effects of immunosuppressive drugs on effector and regulatory T cells.
Wyss J.C., Mottet C., Lechler R., Pascual M., Golshayan D., 2010. pp. 7S-8S dans Annual Meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Ganciclovir exposure under a 450mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical Transplantation, 24 (6) pp. 794-800.
 
Giant warts in a kidney transplant patient: regression with sirolimus.
Kostaki M., Venetz J.P., Nseir G., Meylan P., Sahli R., Pascual M., Laffitte E., 2010. British Journal of Dermatology, 162 (5) pp. 1148-1150.
 
Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
Ciuffreda D., Codarri L., Buhler L., Vallotton L., Giostra E., Mentha G., Morel P., Pantaleo G., Pascual M., 2010. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society, 16 (1) pp. 49-55.
 
Infection and chronic allograft dysfunction.
Dupont P.J., Manuel O., Pascual M., 2010. Kidney International. Supplement, 78 (119) pp. S47-S53.
 
Kidney transplant patients
Manuel Oriol, Baid-Agrawal Seema, Pascual Manuel, 2010. pp. 866-870 dans Cohen J., Opal S.M., Powderly W.G. (eds.) Infectious Diseases chap. 80, Mosby.
 
Natural killer cell receptor-repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
Hadaya K., Avila Y., Valloton L., de Rham C., Bandelier C., Ferrari-Lacraz S., Pascual M., Pantaleo G., Martin P.Y., Buhler L. et al., 2010. Clinical Immunology, 137 (2) pp. 250-260.
 
Prevalence of anti-HLA antibodies after liver transplantation.
Fontana M., Moradpour D., Aubert V., Pantaleo G., Pascual M., 2010. Transplant International, 23 (8) pp. 858-859.
 
Recurrent Hepatitis C After Liver Transplantation Experience of the First 21 Patients Treated in Lausanne
Antonino Anca T., Fontana Massimiliano, Giostra Emiliano, Pascual Manuel, Moradpour Darius, 2010. pp. 20S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
 
Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient.
Mani L.Y., Nseir G., Venetz J.P., Pascual M., 2010. Transplantation, 90 (7) pp. 804-805.
 
Strategies for preventing late-onset cytomegalovirus disease in organ transplant recipients.
Manuel O, Pascual M., 2010. Trends in Transplantation, 4 (1) pp. 36-44.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2010. pp. 35-39 dans Grinyo J.M., Vulto A.G. (eds.) Transplantation for European hospital pharmacists, Pharma Publishing and Media Europe.
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
Perrottet Nancy, Manuel Oriol, Lamoth Frederic, Venetz Jean-Pierre, Sahli Roland, Decosterd Laurent A., Buclin Thierry, Pascual Manuel, Meylan Pascal, 2010. BMC Infectious Diseases, 10 p. 2.
Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Hofbauer G.F., Anliker M., Arnold A., Binet I., Hunger R., Kempf W., Laffitte E., Lapointe A.C., Pascual M., Pelloni F. et al., 2009/07/25. Swiss medical weekly, 139 (29-30) pp. 407-415. Peer-reviewed.
 
Transplantation tolerance: from bench to bedside
Dela Golshayan, Manuel Pascual, 2009/04/01. Trends Transplant, 3 (1) pp. 3-12. Peer-reviewed.
 
Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant?
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Transplantation, 87 (12) pp. 1897-1898.
 
Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
Rosselet A., Vu D.H., Meylan P., Chaubert A.S., Schapira M., Pascual M., Aubert V., Tissot J.D., Duchosal M.A., 2009. Clinical Transplantation, 23 (1) pp. 74-82.
 
Dendritic Cell Modulation for Therapeutic Immunoregulation in Heart Transplantation
Roehrich M.E., Pascual M., Von Segesser L.K., Vogt P., Vassalli G., 2009. pp. 63-80 dans Fleming C.E. (eds.) Heart transplantation : indications and contraindications, procedures and complications, Nova Science.
Die Schweizerische Transplantationskohortenstudie (STCS)
Kohler M., van Delden C., Pascual M., Müller N., Baumann P., Steiger J., 2009. Schweizerische Ärztezeitung, 90 (24) pp. 953-955.
 
Donor's and organ representations in liver, kidney, heart and lung transplantation : a qualitative longitudinal study
Bosisio F., Bridy C., Pralong L., Szymanski J., Pascual M., Piot-Ziegler C., 2009. pp. 225-225 dans Abstracts of the 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
 
Donors/recipients representations about living-kidney donation : P-527
Pralong L., Pascual M., Santiago M., Venetz J.P., Piot-Ziegler C., 2009. p. 226 dans 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
 
Existential values transformation in all organ transplantation : a qualitative prospective study
Piot-Ziegler C., Ruffiner.Boner N. , Cuttelod T., Fonjallaz F., Pilon N., Pascual M., 2009. p. 317 dans From Knowledge to Interventions, 23rd Annual Conference of the European Health Psychology Society (EHPS), Psychology and Health. Peer-reviewed.
 
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplant recipients: a prospective study : P125
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L., Buclin T., Meylan P., 2009. pp. 32S-33S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Ganciclovir Exposure under a 450 mg Daily Dosage of Valganciclovir for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients.
Manuel Oriol, Pascual Manuel, Perrottet Nancy, Lamoth Frederic, Venetz Jean-Pierre, Decosterd Laurent, Buclin Thierry, Meylan Pascal R., 2009. p. 249 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
High Specificity of C4d/CD68 Staining for the Diagnosis of Late Antibody-Mediated Rejection in Heart Transplantation.
Yerly Patrick, Rotmann Samuel, Hullin Roger, von Segesser Ludwig, Pascual Manuel, 2009. p. 656 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Human Immunology, 70 (8) pp. 580-583.
Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability.
Golshayan D., Pascual M., Vogt B., 2009. Therapeutics and Clinical Risk Management, 5 (4) pp. 341-351. Peer-reviewed.
No detectable indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frédéric, Manuel Oriol, Venetz Jean-Pierre, Faouzi Mohamed, Meylan Pascal, Pascual Manuel, 2009. pp. IMI-3, p. 62 dans Genes and Diseases, CHUV Research Day, January 29, 2009, Université de Lausanne, Faculté de biologie et de médecine.
 
Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.
Meier P., Golshayan D., Blanc E., Pascual M., Burnier M., 2009. Journal of the American Society of Nephrology, 20 (6) pp. 1368-1384.
 
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.
Perrottet N., Csajka C., Pascual M., Manuel O., Lamoth F., Meylan P., Aubert J.D., Venetz J.P., Soccal P., Decosterd L.A. et al., 2009. Antimicrobial agents and chemotherapy, 53 (7) pp. 3017-23.
 
Role of the naive and memory CD4+T-cell repertoire in transplantation
Golshayan D., Wyss J.C., Hernandez-Fuentes M., Pascual M., Lechler R., 2009. pp. 3S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Short-course thymoglobulin induction and steroid-free immunosuppressive regimen in renal transplantation
Hadaya K., Venetz J.P., Ponte B., Vallotton L., Buhler L., Pascual M., Martin P.Y., 2009. pp. 6S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Suivi du patient après transplantation cardiaque: monitoring et adaptation de l'immunosuppression [Monitoring and adjustment of immunosuppression after heart transplantation].
Yerly P., Mach F., Kalangos A., Rotman S., von Segesser L., Vogt P., Hullin R., Pascual M., 2009. Revue Médicale Suisse, 5 (205) pp. 1214-1220.
 
The role of significant others in the course of transplantation through the patients points of view : a longitudinal study.
Bridy C., Bosisio F., Pralong L., Pascual M., Piot-Ziegler C., 2009. dans 14th ESOT Congress, European Society for Organ Transplantation. Peer-reviewed.
 
Time-Course In Vivo Trafficking Pattern and Effector Function of Donor-Specific Regulatory T Cells in Response to an Allograft.
Golshayan Dela, Wyss Jean-Christophe, Abulker Caroline Wyss, Schaefer Stephan, Lechler Robert I., Lehr Hans-Anton, Pascual Manuel, 2009. p. 541 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action.
Golshayan D., Wyss J.C., Abulker C.W., Schaefer S.C., Lechler R.I., Lehr H.A., Pascual M., 2009. International Immunopharmacology, 9 (6) pp. 683-688. Peer-reviewed.
 
Usefulness of a routine monitoring of cytomegalovirus viremia after discontinuation of antiviral prophylaxis in kidney transplantation : P117
Boillat N., Pascual M., Venetz J.P., Meylan P.R, Manuel O., 2009. pp. 31S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.
Perrottet N., Decosterd L.A., Meylan P., Pascual M., Biollaz J., Buclin T., 2009. Clinical Pharmacokinetics, 48 (6) pp. 399-418. Peer-reviewed.
 
Absence of BK viremia clearance after low-dose cidofovir therapy in kidney transplant recipients with BK virus associated nephropathy
Lamoth Frederic, Pascual Manuel, Nseir Ghaleb, Venetz Jean-Pierre, Meytan Pascal R., 2008. pp. S12-S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
Allograft Rejection in Kidney Transplantation
Pascual M., 2008. International Transplantation Updates, 10 141, Permanyer.
 
Case report: human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient.
Lamoth F., Jayet P.Y., Aubert J.D., Rotman S., Mottet C., Sahli R., Lautenschlager I., Pascual M., Meylan P., 2008. Journal of Medical Virology, 80 (10) pp. 1804-1807.
 
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E., Pascual M., Nicod M., Delaloye A.B., Duchosal M.A., 2008. Transplantation, 85 (5) pp. 707-712. Peer-reviewed.
 
Cost effectiveness of a new combined immunosuppressive and antiviral regimen on the one-year follow-up of kidney transplant patients.
Manuel Oriol, Kast-Bruechner Mira, Venetz Jean-Pierre, Meylan Pascal R., Pascual Manuel, Wasserfallen Jean-Blaise, 2008. pp. 395-395 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation.
Wasserfallen J.B., Kast-Brückner M., Manuel O., Venetz J.P., Meylan P.R., Pascual M., 2008. International Journal of Technology Assessment In Health Care, 24 (3) pp. 312-317.
 
CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
Crettol S., Venetz J.P., Fontana M., Aubert J.D., Pascual M., Eap C.B., 2008. Therapeutic Drug Monitoring, 30 (6) pp. 689-699. Peer-reviewed.
 
Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.
Leung Ki E.L., Venetz J.P., Meylan P., Lamoth F., Ruiz J., Pascual M., 2008. Clinical Transplantation, 22 (2) pp. 245-249.
 
Disposition of oral valganciclovir during continuous renal replacement therapy in two lung transplant recipients
Perrottet Nancy, Robatel Corinne, Meylan Pascal, Pascual Manuel, Venetz Jean-Pierre, Aubert John-David, Berger Mette M., Decosterd Laurent A., Biollaz Jerome, Buclin Thierry, 2008. p. 566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
Perrottet N., Robatel C., Meylan P., Pascual M., Venetz J.P., Aubert J.D., Berger M.M., Decosterd L.A., Buclin T., 2008. Journal of Antimicrobial Chemotherapy, 61 (6) pp. 1332-1335.
 
Existential questionings during the pretransplantation period: A qualitative phenomenological study
Piot-Ziegler C., Bonner Ruffiner N., Fasseur F., Santiago-Delefosse M., Pascual M., 2008. p. 30 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
Existential values transformation in all organ transplantation: A qualitative prospective study.
Piot-Ziegler Chantal, Ruffiner-Boner Nadja, Cuttelod Therese, Fonjallaz Floriane, Pilon Nathalie, Pascual Manuel, 2008. p. 400 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Experimental Gene Therapy of Heart Transplantation
Vassalli G., Seydoux C., Vogt P., Pascual M., Von Segesser L.K., 2008. pp. - dans Ashan N. (eds.) Chronic allograft failure: natural history, pathophysiology, diagnosis and managements chap. 11, Landes Bioscience.
 
From dialysis to transplantation, illness experience and patients' concerns about future: A longitudinal qualitative study
Piot-Ziegler C., Szymanski J., Ruffiner-Boner N., Fasseur F., Santiago M., Pascual M., 2008. p. 210 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
HCV infection after liver transplantation is associated with lower levels of alloreactive CD4+CD25+CD45RO+IL-7R+high+ T cells
Ciuffreda Donatella, Codarri Laura, Buhler Leo, Giostra Emiliano, Mentha Gilles, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 389 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
Cuttelod M., Pascual A., Baur Chaubert A.S., Cometta A., Osih R., Duchosal M.A., Cavassini M., 2008. AIDS, 22 (4) pp. 549-551.
 
Hepatitis C virus infection in haemodialysis and kidney transplant patients.
Baid-Agrawal S., Pascual M., Moradpour D., Frei U., Tolkoff-Rubin N., 2008. Reviews in Medical Virology, 18 (2) pp. 97-115. Peer-reviewed.
 
Immunosuppression and clinical tolerance of allografts
Golshayan D., Pascual M., 2008. pp. 125-141 dans Arias Rodriguez M. (eds.) Tolerancia y trasplante de organos, Drug Farma.
Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences
Legendre C., Pascual M., 2008. Clinical Infectious Diseases, 46 (5) pp. 732-740. Peer-reviewed.
 
Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences: Reply letter
Legendre C., Pascual M., 2008. Clinical Infectious Diseases, 47 pp. 297-298. Peer-reviewed.
 
In vivo mechanisms leading to transplantation tolerance induced by regulatory T cells
Golshayan D., Wyss J.C., Wyss C., Schaefer S., Lechler R., Lehr H.A., Pascual M., 2008. pp. 6S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.
 
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth Frederic, Pascual Manuel, Erard Veronique, Venetz Jean-Pierre, Nseir Ghaleb, Meylan Pascal, 2008. Antiviral Therapy, 13 (8) pp. 1001-1009. Peer-reviewed.
 
Low-dose valganciclovir is efficacious and safe for prophylaxis of cytomegalovirus infection in kidney transplantation
Perrottet Nancy, Manuel Oriol, Venetz Jean-Pierre, Lamoth Frederic, Decosterd Laurent A., Buclin Thierry, Biollaz Jerome, Meylan Pascal, Pascual Manuel, 2008. pp. 565-566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation.
Golshayan D., Pascual M., 2008. Transplant Immunology, 20 (1-2) pp. 21-28.
 
Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E., Venetz J.P., Aubert J.D., Duchosal M.A., Panizzon R.G., Pascual M., 2008. Dermatology, 217 (1) pp. 87-88.
 
No detectable indirect effects of late-onset Cytomegalovirus disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frederic, Manuel Criol, Meylan Pascal R., Venetz Jean-Pierre, Faouzi Mohammed, Pascual Manuel, 2008. pp. S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
No evidence of indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Manuel Oriol, Lamoth Frederic, Meylan Pascal R., Fellay Jacques, Venetz Jean-Pierre, Pascual Manuel, 2008. p. 527 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Optimal prevention of late-onset cytomegalovirus (CMV) disease and other sequelae of CMV infection in organ transplant recipients - Reply
Legendre Christophe, Pascual Manuel, 2008. Clinical Infectious Diseases, 47 (2) pp. 297-298.
 
Patients' spontaneous discourse on the importance of significant others in the course of transplantation: A qualitative study
Bridy C., Ruffiner-Boner N., Fasseur F., Santiago M., Pascual M., Piot-Ziegler C., 2008. p. 73 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D., Comte D., Cavassini M., Giostra E., Bühler L., Perruchoud M., Heim M.H., Battegay M., Genné D., Mulhaupt B. et al., 2008. European Journal of Immunology, 38 (10) pp. 2665-2677.
 
Prevalence and significance of anti-HILA antibodies after liver transplantation : P236
Fontana M., Moradpour D., Aubert V., Estoppey M., Rotman S., Pascual M., 2008. pp. 54S-55S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Prevalence and significance of anti-HLA antibodies after liver transplantation
Fontana Massimiliano, Moradpour Darius, Aubert Vincent, Estoppey Michele, Rotman Samuel, Pascual Manuel, 2008. pp. S226-S227 dans 14th Annual International Congress of the International Liver Transplantation, Liver Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton Laure, Hadaya Karine, Ciuffreda Donatella, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4+ CD25high CD45RO+ CD127high T-cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton L., Hadaya K., Buhler L., Ciuffreda D., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Prévalence de la dénutrition chez 143 adultes en bilan prétransplantation hépatique. Experience lausannoise de 1997 a 2005 [Prevalence of undernutrition in 143 patients before liver transplantation. The Lausanne experience between 1997 and 2005]
Guex E., Cheseaux M., Coti Bertrand P., Piquet M.A., Bouvry S., Pilon N., Halkic N., Pascual M., Roulet M., 2008. Revue Médicale Suisse, 4 (152) pp. 927-930.
 
Psychological stakes before and after transplantation : a prospective qualitative study
Piot-Ziegler C., Ruffiner-Boner N., Cuttelod T., Fonjallaz F., Szymanski J., Fasseur F., Pilon N., Weigand I., Aubert JD., Pascual M., 2008., ATC Toronto Canada dans American Transplant Conference Book. Peer-reviewed.
 
Quality of life transformation before and after kidney transplantation : a prospective qualitative study
Piot-Ziegler C., Szymanski J., Ruffiner-Boner N., Weigand I., Santiago M., Venetz J-P., Pascual M., 2008., ATS dans American Transplant Conference Book. Peer-reviewed.
 
Quality of life transformations before and after kidney transplantation: A prospective qualitative study.
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Weigand Isabelle, Santiago Marie, Venetz Jean-Pierre, Pascual Manuel, 2008. pp. 400-401 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Rôle du pathologiste en transplantation [The pivotal role of the pathologist in transplantation]
Rotman S., Fontana M., Seydoux C., Venetz J.P., Aubert J.D., Pascual M., 2008. Revue Médicale Suisse, 4 (145) pp. 480-483.
 
Spontaneous discourse on employment status and professional identity of patients waiting for solid organ transplantation
Fonjallaz F., Fasseur F., Ruffiner-Boner N., Cuttelod T., Szymanski J., Santiago M., Pilon N., Venetz J.P., Pascual M., Piot-Ziegler C., 2008. pp. 488-495 dans Weimar W., Bos M.A., Busschbach J.J. (eds.) Organ Transplantation: Ethical, Legal and Psychosocial Aspects. Towards a Common European Policy, Pabst Science Publishers.
 
Switch to Sirolimus-based immunosuppresion in stable renal transplant recipients
Nseir G., Venetz J.P, Hadaya K., Buhler L., Martin P.Y., Pascual M., 2008. pp. 18S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
The presence of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population correlates with the clinical status of kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Hadaya Karine, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
The presence of a CD4+ CD25high CD45RO+ CD127high T-cell population correlates with the clinical status of kidney transplant recipients
Vallotton L., Codarri L., Ciuffreda D., Hadaya K., Buhler L., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.
Golshayan D., Pascual M., 2008. Drugs, 68 (15) pp. 2113-2130.
 
Transplantation hépatique : introduction en Suisse d'un nouveau système d'allocation des organes [Liver transplantation: new organ allocation system in Switzerland]
Fontana M., Giostra E., Pilon N., Michetti P., Mentha G., Pascual M., Moradpour D., 2008. Revue Médicale Suisse, 4 (141) pp. 221-223.
 
Transplantation rénale: y a-t-il un âge limite ?
Kissling S., Pascual M., Venetz JP., 2008. Geriatrie Pratique, 1 pp. 15-20.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2008. EJHP Practice, 14 (5) pp. 21-24.
 
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?
Lamoth F., Manuel O., Venetz J.P., Faouzi M., Meylan P., Pascual M., 2008. Transplantation, 86 (9) pp. 1323-1324.
 
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency.
Manuel O., Tarr P.E., Venetz J.P., Trendelenburg M., Meylan P.R., Pascual M., 2007/09. Transplant Infectious Disease, 9 (3) pp. 214-218. Peer-reviewed.
 
Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples
Perrottet N., Beguin A., Meylan P., Pascual M., Manuel O., Buclin T., Biollaz J., Decosterd L. A., 2007/06. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 852 (1-2) pp. 420-9.
 
New treatments for acute humoral rejection of kidney allografts.
Venetz J.P., Pascual M., 2007/05. Expert Opinion on Investigational Drugs, 16 (5) pp. 625-633.
 
Cytomegalovirus in transplantation - challenging the status quo.
Fishman J.A., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., Sgarabotto D., Torre-Cisneros J., Uknis M.E., 2007/04. Clinical Transplantation, 21 (2) pp. 149-158.
 
Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.
Manuel O., Pascual M., Trendelenburg M., Meylan P.R., 2007/02. Transplantation, 83 (3) pp. 359-362. Peer-reviewed.
 
Association between mannose-binding lectin (MBL) deficiency and cytomegalovirus (CMV) infection after kidney transplantation
Trendelenburg Marten, Manuel Oriol, Pascual Manuel, Schifferli Jürg A., Meylan Pascal, 2007. p. 251 dans 21st International Complement Workshop, Molecular Immunology. Peer-reviewed.
 
Association between mannose-binding lectin deficiency and cytornegalovirus infection course after organ transplantation.
Manuel Oriol, Pascual Manuel, Trendelenburg Marten, Muheim Carmen, Meylan Pascal R., 2007. p. 501 dans Annual American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
Fontana M., Ciuffreda D., Moradpour D., Pascual M., 2007. Transplantation, 83 (4) pp. 525-526.
 
Cost-effectiveness of a new combined immunosupressive regimen in kidney transplantation
Wasserfallen Jean-Blaise, Kast-Brückner Mira, Manuel Oriol, Venetz Jean-Pierre, Meylan Pascal, Pascual Manuel, 2007. pp. 40S dans Annual Conference of the Swiss Respiratory Society, Swiss Medical Weekly. Peer-reviewed.
 
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
Ciuffreda D., Pantaleo G., Pascual M., 2007. Transplant International, 20 (8) pp. 649-658. Peer-reviewed.
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007. Swiss Medical Weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
Codarri L., Vallotton L., Ciuffreda D., Venetz J.P., Garcia M., Hadaya K., Buhler L., Rotman S., Pascual M., Pantaleo G., 2007. Journal of Experimental Medicine, 204 (7) pp. 1533-1541. Peer-reviewed.
 
From current immunosuppressive strategies to clinical tolerance of allografts.
Golshayan D., Buhler L., Lechler R.I., Pascual M., 2007. Transplant International, 20 (1) pp. 12-24. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University